comprehensive -WSS

comprehensive

author：fashion 2025-09-03 15:19:37 - browse：76799

U.S. Sen. Bernie Sanders sets his hands on two chairs as two people set up a board displaying a "price of drugs" chart behind him — politics coverage from STAT — Sen. Bernie Sanders has used his leadership of a Senate committee to pressure drugmakers to lower their prices. Kevin Dietsch/Getty Images

WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him.

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’s now progressed to demanding that Novo Nordisk cut its price for its novel, wildly popular diabetes and weight-loss drugs.

Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. He’s threatened subpoenas, held a prominent nominee hostage, and initiated investigations to get his way. It’s a sharp departure from the modest, bipartisan ambitions that more disciplined, discreet leaders of the committee have taken in years past, and sets the bar for how much can be accomplished using the full extent of the bully pulpit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Novo Nordisk to buy Cardior, building up pipeline of heart drugs

WSS

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Eye stem cell transplant could help restore vision in injured people

New definition of a human embryo proposed amid rapid advances

Asbestos ban is immediate, but health effects will linger for decades

ActiGraph execs on goal of drug approvals with digital endpoints

Testing GLP

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

Virginia high school admissions case could be legal follow

Bring on the sabbaticals for nurses

Dobbs anniversary: the lost opportunity of abortion as health care

Adam's Take: Intra

What does generative AI mean for health care? We asked experts

Asbestos ban is immediate, but health effects will linger for decades

Hollywood unions extend contract negotiations for actors

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

As demand for Covid shots wanes, Moderna seeks its next success

Cancer, immunology, HIV research ensnared in fetal tissue politics

hotspot

Hilary expected to bring catastrophic, life

Texas board proposes rules on abortion law emergency exemption

Chinese researcher claims birth of first gene

As Maui death toll rises, number of missing remains unclear

U.K. officials, researchers try to ease path for bespoke genetic treatments

Eye stem cell transplant could help restore vision in injured people

leisure time

explore

Wikipedia

focus